{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26"}]}],"title":"Compliance"},{"categories":[{"measurements":[{"groupId":"OG000","value":"8"}]}],"title":"No Compliance"}],"denoms":[{"counts":[{"groupId":"OG000","value":"34"}],"units":"Participants"}],"description":"CMV reactivation patients completed 6-week GCV therapy.","groups":[{"description":"Patients with CMV reactivation detected by blood culture or PCR test.","id":"OG000","title":"Compliance Among Patients With CMV Reactivation"}],"paramType":"NUMBER","populationDescription":"Among the 36 patients with CMV reactivation, two patients are in-evaluable for compliance.","reportingStatus":"POSTED","timeFrame":"From first ganciclovir positive test to the end of the 6th week GCV therapy","title":"Compliance Rate Among Patients With CMV Reactivation","type":"PRIMARY","unitOfMeasure":"participants"}